FAGGIUOLO, Roberto
FAGGIUOLO, Roberto
Dip. SCIENZE ONCOLOGICHE - Candiolo (attivo dal 01/01/2002 al 30/04/2013)
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer
2004-01-01 MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M
Continuation of trastuzumab beyond disease progression
2005-01-01 MONTEMURRO F; FAGGIUOLO R; REDANA S; DONADIO M; MINISCHETTI M; DURANDO A; VIETTI-RAMUS G; BUOSI R; AGLIETTA M
Jaw complications in breast and prostate cancer patients treated with zoledronic acid
2006-01-01 ORTEGA C; FAGGIUOLO R; VORMOLA R; MONTEMURRO F; NANNI D; GOIA F; AGLIETTA M
Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis
2007-01-01 ORTEGA C; MONTEMURRO F; FAGGIUOLO R; VORMOLA R; NANNI D; GOIA F; GILARDINO MO; AGLIETTA M
Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach
2006-01-01 SPERTI E; FAGGIUOLO R; GERBINO A; MAGNINO A; MURATORE A; ORTEGA C; FERRARIS R; LEONE F; CAPUSSOTTI L; AGLIETTA M
Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer
2005-01-01 MAGNINO A ; GATTI M; MASSUCCO P; SPERTI E; FAGGIUOLO R; REGGE D; CAPUSSOTTI L; GABRIELE P; AGLIETTA M
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study.
2003-01-01 MONTEMURRO F ;CHOA G ;FAGGIUOLO R ;SPERTI E ;CAPALDI A ;DONADIO M ;MINISCHETTI M ;SALOMONE A ;VIETTI-RAMUS G ;ALABISO O ;AGLIETTA M
Thyroid hormone levels in human breast cyst fluid.
1984-01-01 ANGELI A ;DOGLIOTTI L ;AGRIMONTI F ;FAGGIUOLO R ;CAVALLO R ;TIBO A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer | 2004 | MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M | |
| Continuation of trastuzumab beyond disease progression | 2005 | MONTEMURRO F; FAGGIUOLO R; REDANA S; DONADIO M; MINISCHETTI M; DURANDO A; VIETTI-RAMUS G; BUOSI R; AGLIETTA M | |
| Jaw complications in breast and prostate cancer patients treated with zoledronic acid | 2006 | ORTEGA C; FAGGIUOLO R; VORMOLA R; MONTEMURRO F; NANNI D; GOIA F; AGLIETTA M | |
| Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis | 2007 | ORTEGA C; MONTEMURRO F; FAGGIUOLO R; VORMOLA R; NANNI D; GOIA F; GILARDINO MO; AGLIETTA M | |
| Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach | 2006 | SPERTI E; FAGGIUOLO R; GERBINO A; MAGNINO A; MURATORE A; ORTEGA C; FERRARIS R; LEONE F; CAPUSSOTTI L; AGLIETTA M | |
| Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer | 2005 | MAGNINO A ; GATTI M; MASSUCCO P; SPERTI E; FAGGIUOLO R; REGGE D; CAPUSSOTTI L; GABRIELE P; AGLIETTA M | |
| Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study. | 2003 | MONTEMURRO F ;CHOA G ;FAGGIUOLO R ;SPERTI E ;CAPALDI A ;DONADIO M ;MINISCHETTI M ;SALOMONE A ;VIETTI-RAMUS G ;ALABISO O ;AGLIETTA M | |
| Thyroid hormone levels in human breast cyst fluid. | 1984 | ANGELI A ;DOGLIOTTI L ;AGRIMONTI F ;FAGGIUOLO R ;CAVALLO R ;TIBO A |